# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000885590-24-000011
Filing Date
2024-02-22
Accepted
2024-02-22 17:04:26
Documents
168
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | bhc-20231231.htm iXBRL | 10-K | 4723845
2 | EX-10.55 | exhibit1055.htm | EX-10.55 | 1168440
3 | EX-21.1 | exhibit2112023ye.htm | EX-21.1 | 108749
4 | EX-23.1 | exhibit2312023ye.htm | EX-23.1 | 2305
5 | EX-31.1 | exhibit3112023ye.htm | EX-31.1 | 9798
6 | EX-31.2 | exhibit3122023ye.htm | EX-31.2 | 9823
7 | EX-32.1 | exhibit3212023ye.htm | EX-32.1 | 6330
8 | EX-32.2 | exhibit3222023ye.htm | EX-32.2 | 6431
9 | EX-97 | exhibit97.htm | EX-97 | 43423
15 |  | bhc-20231231_g1.jpg | GRAPHIC | 31452
| Complete submission text file | 0000885590-24-000011.txt |  | 25742267

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | bhc-20231231.xsd | EX-101.SCH | 162467
11 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | bhc-20231231_cal.xml | EX-101.CAL | 151700
12 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | bhc-20231231_def.xml | EX-101.DEF | 974201
13 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | bhc-20231231_lab.xml | EX-101.LAB | 1751621
14 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | bhc-20231231_pre.xml | EX-101.PRE | 1334586
170 | EXTRACTED XBRL INSTANCE DOCUMENT | bhc-20231231_htm.xml | XML | 4419429

Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-14956 | Film No.: 24665921
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)